Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells-Reference-Cited by-同舟云学术

Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells

Published:2014-12 Issue:6 Volume:16 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Ogba Ndiya,Manning Nicole G,Bliesner Brian S,Ambler S Kelly,Haughian James M,Pinto Mauricio P,Jedlicka Paul,Joensuu Kristiina,Heikkilä Päivi,Horwitz Kathryn B

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/article/10.1186/s13058-014-0489-4/fulltext.html

Reference56 articles.

1. Dunnwald LK, Rossing MA, Li CI: Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 2007, 9: R6-10.1186/bcr1639.

2. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, et al: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010, 28: 2784-2795. 10.1200/JCO.2009.25.6529.

3. Demicheli R, Biganzoli E, Ardoino I, Boracchi P, Coradini D, Greco M, Moliterni A, Zambetti M, Valagussa P, Gukas ID, Bonadonna G: Recurrence and mortality dynamics for breast cancer patients undergoing mastectomy according to estrogen receptor status: different mortality but similar recurrence. Cancer Sci. 2010, 101: 826-830. 10.1111/j.1349-7006.2009.01472.x.

4. Zhang XH, Giuliano M, Trivedi MV, Schiff R, Osborne CK: Metastasis dormancy in estrogen receptor-positive breast cancer. J Clin Oncol. 2013, 19: 6389-6397.

5. Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO, Gelmon K: Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010, 28: 3271-3277. 10.1200/JCO.2009.25.9820.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumor progestins activity: Cytostatic effect and immune response;Steroids;2024-10

2. NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence;Clinical and Translational Medicine;2024-02

3. Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance;Genes & Diseases;2024-01

4. NCAPH Drives Breast Cancer Progression and Identifies a Gene Signature that Predicts Luminal A Tumor Recurrence;2023-10-16

5. Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysis;Breast Cancer Research and Treatment;2023-10-03